Your browser doesn't support javascript.
loading
Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination.
Wu, Weijian; Xu, Huiying; Liao, Chenyang; Wang, Youqiao; Wu, Ruirui; Wu, Jiaxin; Zheng, Wenlv; Li, Yunzhi; Jin, Chaoying; Zhao, Yuxuan; Quan, Junmin; Yue, Xin; Bu, Xianzhang.
Afiliação
  • Wu W; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Xu H; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Liao C; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Wang Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Wu R; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Wu J; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Zheng W; State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Li Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Jin C; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Zhao Y; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Quan J; State Key Laboratory of Chemical Oncogenomics, Guangdong Provincial Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Yue X; Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. yuex5@mail.sysu.edu.cn.
  • Bu X; Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. yuex5@mail.sysu.edu.cn.
Cell Oncol (Dordr) ; 45(6): 1347-1361, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36205846

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Interferon Tipo I / Interferon beta / Ubiquitina Tiolesterase / Imunidade Adaptativa Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Interferon Tipo I / Interferon beta / Ubiquitina Tiolesterase / Imunidade Adaptativa Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article